Clinical trial
Continuous Interscalene Block (CISB) Versus Single Injection Interscalene Block in Those Undergoing Shoulder Surgery in the Ambulatory Setting
NCT01385449 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Continuous Interscalene Block (CISB) Versus Single Injection Interscalene Block in Those Undergoing Shoulder Surgery in the Ambulatory Setting
- Lead sponsor
- University of Wisconsin, Madison
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- June 30, 2011
- Completion date
- February 29, 2016
- Enrollment
- 73 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.